# Open-Label of SPN-820 in Adults With Major Depressive Disorder

> **NCT06235905** · PHASE2 · COMPLETED · sponsor: **Navitor Pharmaceuticals, Inc.** · enrollment: 40 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** NV-5138

## Key facts

- **NCT ID:** NCT06235905
- **Lead sponsor:** Navitor Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-15
- **Primary completion:** 2024-08-18
- **Final completion:** 2024-08-18
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06235905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06235905, "Open-Label of SPN-820 in Adults With Major Depressive Disorder". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06235905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*